Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 10036 clinical trials
Featured trial
Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease

This study will determine if a dexamethasone mouth rinse can reduce the risk of developing oral chronic graft-versus-host disease (cGVHD) in patients who have undergone a bone marrow (stem cell) transplant procedure. cGVHD is a common complication of stem cell transplantation, resulting from the donor cells attacking the transplant recipient's …

graft-versus-host disease
graft versus host disease
  • 164 views
  • 22 Dec, 2020
  • 1 location
Featured trial
Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-Tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People who have cancer tend to get sick more often. This is in part because of the cancer treatments they get. Because of this, they may get shingles. Scientists had thought people with chronic lymphocytic leukemia (CLL) should not get the shingles vaccine. Now there is a new shingles …

lymphoma
chronic lymphocytic leukemia
cancer
ibrutinib
acalabrutinib
  • 238 views
  • 09 Apr, 2019
  • 1 location
Featured trial
Response to the HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) Patients that are Treatment Naive or Receiving Bruton s-tyrosine Kinase Inhibitor (BTK-I) Therapy

Background: People with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) tend to get infections more easily. This is because their immune systems are weakened. Hepatitis B is a virus that can be transmitted when body fluids from an infected person enter the body of an uninfected person. This …

lymphoma
chronic lymphocytic leukemia
acalabrutinib
ibrutinib
  • 67 views
  • 09 Apr, 2019
  • 1 location
Featured trial
HERV-E TCR Transduced Autologous T Cells in People With Metastatic Clear Cell Renal Cell Carcinoma

Gene transfer is a new cancer therapy takes white blood cells from a person and grows them in a lab. The cells are changed with a virus to attack tumor cells, then returned to the person. Researchers want to see if this therapy fights kidney cancer cells. Metastatic renal cell …

metastatic cancer
clear cell carcinoma
primary cancer
carcinoma
renal cell cancer
  • 210 views
  • 22 Dec, 2020
  • 1 location
Featured trial
A Phase 2 Study of INCMGA00012 in Participants With Metastatic Merkel Cell Carcinoma

The purpose of this study is to assess the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC).  

merkel cell carcinoma
metastatic cancer
cancer
carcinoma
measurable disease
  • 101 views
  • 10 May, 2022
  • 7 locations
Featured trial
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors

The purpose of this open-label nonrandomized Phase 1/2 study is to evaluate INCB001158 in combination with chemotherapy in participants with advanced/metastatic solid tumors.  

metastatic cancer
cancer
solid tumor
measurable disease
solid tumors
  • 38 views
  • 10 May, 2022
  • 13 locations
Featured trial
Prostate Cancer with/without bone metastasis

Prostate Cancer with/without bone metastasis

  • 364 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A study to evaluate preventative secondary stroke treatments.

A study to evaluate preventative secondary stroke treatments.

  • 526 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Participants with agitation secondary to dementia of the Alzheimer's type

Participants with agitation secondary to dementia of the Alzheimer's type. Eligible participants for this study must have a diagnosis of probable AD and must have clinically meaningful agitation

mini-mental state examination
mental state examination
dementia
agitation
  • 0 views
  • 29 Jul, 2021
  • 1 location
Featured trial
A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis

A Phase 2 Double-Blind, Placebo Controlled Multi-Center Study to Evaluate the Efficacy and Safety of Tcelna in Subjects With Secondary Progressive Multiple Sclerosis

  • 204 views
  • 08 Nov, 2020
  • 1 location